RATIONALE: Individuals learn associations between alcohol's sensory properties and intoxication, with such conditioned stimuli (CS) becoming involved in craving and relapse. However, these CS also carry idiosyncratic associations. OBJECTIVES: This study aimed to test brain responses to novel CS conditioned with alcohol intoxication. METHODS:Fourteen heavy drinkers (age 24.9 ± 3.2) performed areaction time task with embedded novel geometric CS and were told only that the task was to measure alcohol's effect on speed. Rapid intravenous alcohol infusion (the unconditioned stimulus; UCS) began with the appearance of a CS+, using pharmacokinetic modeling to increment breath alcohol by ~18 mg% in 200 s per each of six CS-UCS pairings. Placebo-saline infusion with CS- used the same infusion parameters in same-day randomized/counterbalanced sessions. The next morning subjects, connected to inactive intravenous pumps, underwent functional magnetic resonance imaging (fMRI) of the same task with mixed brief presentations of CS+, CS-, and irrelevant CS and were told that alcohol could be infused at any time during imaging. RESULTS:CS- responses were significantly greater than those of CS+ in medial frontal cortex. Notably, CS+ responses were negative, suggesting reduced neural activity. Negative activity was most pronounced in early scans, extinguishing with time. As subjects were told that alcohol could be administered in fMRI, a CS+ without alcohol is similar to a negative prediction error, with associated reduced frontal activity during withheld reward. CONCLUSIONS: Novel stimuli relatively free of demand characteristics can be classically conditioned to intermittent brain exposure of even low alcohol concentrations, permitting imaging studies of conditioned alcohol expectancies.
RCT Entities:
RATIONALE: Individuals learn associations between alcohol's sensory properties and intoxication, with such conditioned stimuli (CS) becoming involved in craving and relapse. However, these CS also carry idiosyncratic associations. OBJECTIVES: This study aimed to test brain responses to novel CS conditioned with alcohol intoxication. METHODS: Fourteen heavy drinkers (age 24.9 ± 3.2) performed a reaction time task with embedded novel geometric CS and were told only that the task was to measure alcohol's effect on speed. Rapid intravenous alcohol infusion (the unconditioned stimulus; UCS) began with the appearance of a CS+, using pharmacokinetic modeling to increment breathalcohol by ~18 mg% in 200 s per each of six CS-UCS pairings. Placebo-saline infusion with CS- used the same infusion parameters in same-day randomized/counterbalanced sessions. The next morning subjects, connected to inactive intravenous pumps, underwent functional magnetic resonance imaging (fMRI) of the same task with mixed brief presentations of CS+, CS-, and irrelevant CS and were told that alcohol could be infused at any time during imaging. RESULTS:CS- responses were significantly greater than those of CS+ in medial frontal cortex. Notably, CS+ responses were negative, suggesting reduced neural activity. Negative activity was most pronounced in early scans, extinguishing with time. As subjects were told that alcohol could be administered in fMRI, a CS+ without alcohol is similar to a negative prediction error, with associated reduced frontal activity during withheld reward. CONCLUSIONS: Novel stimuli relatively free of demand characteristics can be classically conditioned to intermittent brain exposure of even low alcohol concentrations, permitting imaging studies of conditioned alcohol expectancies.
Authors: Amir Shmuel; Essa Yacoub; Josef Pfeuffer; Pierre Francois Van de Moortele; Gregor Adriany; Xiaoping Hu; Kamil Ugurbil Journal: Neuron Date: 2002-12-19 Impact factor: 17.173
Authors: Jessica Weafer; Mario Dzemidzic; William Eiler; Brandon G Oberlin; Yang Wang; David A Kareken Journal: Psychiatry Res Date: 2015-05-07 Impact factor: 3.222
Authors: Nicole M Strang; Eric D Claus; Vijay A Ramchandani; Ariel Graff-Guerrero; Isabelle Boileau; Christian S Hendershot Journal: Psychopharmacology (Berl) Date: 2014-08-12 Impact factor: 4.530
Authors: Brandon G Oberlin; Mario Dzemidzic; William J A Eiler; Claire R Carron; Christina M Soeurt; Martin H Plawecki; Nicholas J Grahame; Sean J O'Connor; David A Kareken Journal: Psychopharmacology (Berl) Date: 2018-08-01 Impact factor: 4.530
Authors: Kathryne Van Hedger; Sarah K Keedy; Leah M Mayo; Markus Heilig; Harriet de Wit Journal: Neuropsychopharmacology Date: 2018-01-30 Impact factor: 7.853
Authors: William J A Eiler; Mario Dzemidzic; K Rose Case; Robert V Considine; David A Kareken Journal: Chemosens Percept Date: 2012-03-01 Impact factor: 1.833
Authors: Judith Charpentier; Mario Dzemidzic; John West; Brandon G Oberlin; William J A Eiler; Andrew J Saykin; David A Kareken Journal: Psychiatry Res Neuroimaging Date: 2016-01-04 Impact factor: 2.376